drugset / Trial / NCT06318845
Phase 1 Study of DHP2302R1 and DHP2302R2 in Healthy Adult Volunteers
RandomizedCrossoverOpen-labelPrevention
Summary
The purpose of this study is to investigate the safety and drug interaction of DHP2302R1 and DHP2302R2 when administered alone versus in combination in healthy South Korean adult participants.
Timeline
- Start
- 2024-03-04
- Primary completion
- 2024-04-26
- Completion
- 2024-05-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DHP2302R1 | Unknown | 75 mg | — |
| Subject | DHP2302R2 | Unknown | 50 mg | — |
Indications
No indication recorded.